4
Changes in Ownership
Protagonist Therapeutics, Inc Filed Acc 0001104659-25-024062
Chief Financial Officer sold 24,903 shares at $58.73 ($1,462,553)
- Chief Financial Officer acquired 24,903 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ali Asif Chief Financial Officer | 2025-03-12 | Option exercise | +15,203 | $12.17 | $185,021 | 78,024 | D: show line 1 in the form |
| Ali Asif Chief Financial Officer | 2025-03-12 | Option exercise | +9,700 | $19.19 | $186,143 | 87,724 | D: show line 2 in the form |
| Ali Asif Chief Financial Officer | 2025-03-12 | Sale | −24,903 | $58.73 | $1,462,553 | 62,821 | D: show line 3 in the form |
| Open-market sales · 24,903 sh · avg $58.73 · $1,462,553 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ali Asif Chief Financial Officer | 2025-03-12 | Option exercise · Stock Option (right to buy) | −15,203 | 30,547 | D: show line 4 in the form | ||
| Ali Asif Chief Financial Officer | 2025-03-12 | Option exercise · Stock Option (right to buy) | −9,700 | 66,800 | D: show line 5 in the form |
Loading xslF345X05/tm259281-1_4seq1.xml…